Pancreatic Cancer Research

ResearcherAffiliated Hospital of Jiangsu UniversityActive in the last 2 years

Xin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1924-7463; OpenAlex author ID A5100327907. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Radiotherapy followed by metformin neoadjuvant therapy drives superior pancreatic cancer ferroptosis and augments anti-tumor immunity. Co-author DOI 10.1016/j.fmre.2025.12.010↗
  2. O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis. Co-author DOI 10.7150/ijbs.71520↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haitao Zhu · 2 shared papers, 2022–2026 · strength 0.42
  2. Dongqing Wang · 1 shared paper, 2026 · strength 0.27
  3. Xiang Liao · 1 shared paper, 2026 · strength 0.27
  4. Wenjin Xu · 1 shared paper, 2026 · strength 0.27
  5. Aihua Gong · 1 shared paper, 2022 · strength 0.15
  6. Yanfang Liu · 1 shared paper, 2022 · strength 0.15
  7. Mengqi Liu · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.